Cargando…
Sulfonamidoboronic Acids as “Cross-Class” Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii
Acinetobacter baumannii is a Gram-negative organism listed as an urgent threat pathogen by the World Health Organization (WHO). Carbapenem-resistant A. baumannii (CRAB), especially, present therapeutic challenges due to complex mechanisms of resistance to β-lactams. One of the most important mechani...
Autores principales: | Introvigne, Maria Luisa, Beardsley, Trevor J., Fernando, Micah C., Leonard, David A., Wallar, Bradley J., Rudin, Susan D., Taracila, Magdalena A., Rather, Philip N., Colquhoun, Jennifer M., Song, Shaina, Fini, Francesco, Hujer, Kristine M., Hujer, Andrea M., Prati, Fabio, Powers, Rachel A., Bonomo, Robert A., Caselli, Emilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135033/ https://www.ncbi.nlm.nih.gov/pubmed/37107006 http://dx.doi.org/10.3390/antibiotics12040644 |
Ejemplares similares
-
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a
Class of β-Lactamase Inhibitors against Acinetobacter baumannii
Cephalosporinase
por: Caselli, Emilia, et al.
Publicado: (2020) -
Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii
por: Powers, Rachel A., et al.
Publicado: (2014) -
Synthesis of
a Novel Boronic Acid Transition State
Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits Acinetobacter-Derived Cephalosporinase Variants with an
Expanded-Substrate Spectrum
por: Powers, Rachel A., et al.
Publicado: (2023) -
Dissemination of Class A Cephalosporinases and Class D Carbapenemases in Escherichia coli Isolates From a Tertiary Hospital in Sudan
por: Khalid, Khalid E
Publicado: (2023) -
1250. Novel Boronic Acid Transition State Analogs (BATSI) with in vitro inhibitory activity against class A, B and C β-lactamases
por: Mojica, Maria F, et al.
Publicado: (2020)